VYNE · Yarrow Bioscience Inc

Summary

VYNE Therapeutics Inc. filed an 8-K on March 11, 2026, providing notice of delisting or failure to satisfy a continued listing rule or standard, as previously disclosed in a prior Current Report on Form 8-K. Specific details of the delisting event were not provided in this filing.

Key takeaways

• Form 8-K filed on 2026-03-11
• Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
• References prior 8-K disclosure
• Items listed as N/A in filing summary